Trastuzumab emtansine

Maintaining Durable QOL in HER2+ Breast Cancer Patients: Trastuzumab Deruxtecan

Results published in Annals of Oncology indicate that Trastuzumab deruxtecan (T-DXd; Enhertu) showed superior health-related quality-of-life (HRQOL) outcomes compared to ...